HF2426 (Legislative Session 94 (2025-2026))

Plant canopy that medical cannabis combination business may use to cultivate cannabis that will be sold as medical cannabis flower or medical cannabinoid products increased.

Related bill: SF2165

AI Generated Summary

Purpose of the Bill

The primary purpose of this bill is to modify the regulations around the cultivation and sale of medical cannabis in Minnesota. It focuses on increasing the plant canopy for medical cannabis combination businesses, which will allow these businesses to grow more cannabis plants for the purpose of producing medical cannabis flowers and cannabinoid products.

Main Provisions

  • Expanded Licensing Abilities: The bill allows holders of a medical cannabis combination business license to grow cannabis plants and harvest cannabis flowers for both adult use and medical purposes. This includes the production of cannabis concentrates and medical cannabinoid products.
  • Manufacturing Rights: License holders are authorized to manufacture various products such as cannabis concentrates, hemp concentrates with THC greater than 0.3%, artificially derived cannabinoids, and both medical and adult-use cannabis products.
  • Purchasing and Sourcing: Businesses can purchase cannabis seedlings, cannabis flower, and concentrates from other licensed businesses, including microbusinesses, mezzobusinesses, and hemp growers or processors.
  • Sales and Distribution: License holders are permitted to manufacture, package, label, and sell medical cannabis flowers, medical cannabinoid products, and adult-use cannabis products to licensed businesses and registered individuals, including patients and caregivers.
  • Transportation: Businesses can transport and deliver their products to various entities, such as medical cannabis processors, retailers, and registered patients and their families.

Significant Changes to Existing Law

  • The bill amends the existing regulation by increasing the plant canopy allowed for cultivation and changes the requirements related to licensing, allowing more flexibility and business activities for license holders.
  • It repeals specific subdivisions of the current statute to streamline operations and permissions for medical cannabis businesses.

Relevant Terms

  • Medical cannabis
  • Cannabis flower
  • Cannabinoid products
  • Cannabis concentrate
  • Medical cannabis combination business
  • Licensed businesses
  • Hemp concentrate
  • Delta-9 tetrahydrocannabinol (THC)
  • Adult-use cannabis

Bill text versions

Past committee meetings

Actions

DateChamberWhereTypeNameCommittee Name
March 16, 2025HouseFloorActionIntroduction and first reading, referred toCommerce Finance and Policy
April 01, 2025HouseFloorActionAuthor stricken

Citations

 
[
  {
    "analysis": {
      "added": [
        "Expands authorized actions for medical cannabis businesses."
      ],
      "removed": [
        "Prohibits ownership of multiple cannabis-related businesses without appropriate licenses."
      ],
      "summary": "This bill relates to medical cannabis and mentions restrictions under section 152.25, subdivision 1.",
      "modified": [
        "Clarifies that a medical cannabis combination business can perform certain actions without additional endorsements."
      ]
    },
    "citation": "152.25",
    "subdivision": "subdivision 1"
  }
]